RORγt eTACs mediate oral tolerance and Treg induction
The immune system must distinguish pathogens from innocuous dietary antigens, but the precise mechanisms and cellular actors remain unclear. Here, we demonstrate that RORγt-lineage APCs are required for oral tolerance. Using lineage tracing and single-cell sequencing, we show these APCs consist of three principal populations: type 3 innate lymphoid cells (ILC3s), RORγt-lineage dendritic cells, and cells expressing Aire called RORγt eTACs (R-eTACs)-also known as Janus or Thetis cells. We show that R-eTACs, but not ILC3s, are required for oral tolerance induction. We find R-eTACs are of probable myeloid origin and uniquely express integrin β8 (Itgb8). Both MHCII and Itgb8 expression in RORγt-lineage cells are necessary to induce food-specific regulatory T cells. Mice lacking R-eTACs or with deletion of MHCII or Itgb8 in the RORγt lineage fail to generate Tregs and instead develop a T-follicular helper response with elevated antigen-specific antibodies. These findings establish R-eTACs as critical mediators of oral tolerance and suggest novel cellular targets to modulate immune tolerance.
Authors
- Matthew P. Arvedson (ORCID: https://orcid.org/0000-0001-7717-0188)
- Vasilis Ntranos (ORCID: https://orcid.org/0000-0002-2477-0670)
- Im‐Hong Sun (ORCID: https://orcid.org/0000-0003-0288-2062)
- James M. Gardner (ORCID: https://orcid.org/0000-0003-3470-9520)
- Richard M. Locksley (ORCID: https://orcid.org/0000-0002-5468-6867)
- Martín Valdearcos (ORCID: https://orcid.org/0000-0002-5784-2458)
- Roberto R. Ricardo-González (ORCID: https://orcid.org/0000-0002-6135-4035)
- Anita Qualls (ORCID: https://orcid.org/0000-0003-0576-8863)
- Joe Germino (ORCID: https://orcid.org/0000-0003-3939-3342)
- Jiaxi Wang (ORCID: https://orcid.org/0000-0001-6043-9953)
- Sheng Zhong (ORCID: https://orcid.org/0000-0001-6908-3519)
- Juan Du (ORCID: https://orcid.org/0000-0001-7428-0576)
- Han Yin (ORCID: https://orcid.org/0009-0007-5721-3022)
- Nolan K. Horner (ORCID: https://orcid.org/0009-0004-9388-5676)
Institutions
- Howard Hughes Medical Institute (US)
- University of California, San Francisco (US)
Publication Details
- Journal
- The Journal of Experimental Medicine
- Published
- 2025-04-29
- DOI
- https://doi.org/10.1084/jem.20250573
- Citations
- 28
- Primary Topic
- IL-33, ST2, and ILC Pathways
- Type
- article
- Field-Weighted Citation Impact
- 22.33
Funders
- Burroughs Wellcome Fund
- W. M. Keck Foundation
- Achievement Rewards for College Scientists Foundation
- Parker Institute for Cancer Immunotherapy
- National Institutes of Health